152 related articles for article (PubMed ID: 18270169)
1. Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation.
Natoli G; Chiocca S
Sci Signal; 2008 Jan; 1(1):pe1. PubMed ID: 18270169
[TBL] [Abstract][Full Text] [Related]
2. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
Saccani S; Marazzi I; Beg AA; Natoli G
J Exp Med; 2004 Jul; 200(1):107-13. PubMed ID: 15226358
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.
Hochrainer K; Pejanovic N; Olaseun VA; Zhang S; Iadecola C; Anrather J
Nucleic Acids Res; 2015 Nov; 43(20):9889-904. PubMed ID: 26476452
[TBL] [Abstract][Full Text] [Related]
4. PDLIM1 inhibits NF-κB-mediated inflammatory signaling by sequestering the p65 subunit of NF-κB in the cytoplasm.
Ono R; Kaisho T; Tanaka T
Sci Rep; 2015 Dec; 5():18327. PubMed ID: 26679095
[TBL] [Abstract][Full Text] [Related]
5. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
6. p65 controls NF-κB activity by regulating cellular localization of IκBβ.
Valovka T; Hottiger MO
Biochem J; 2011 Mar; 434(2):253-63. PubMed ID: 21158742
[TBL] [Abstract][Full Text] [Related]
7. Suppression of p65 phosphorylation coincides with inhibition of IkappaBalpha polyubiquitination and degradation.
Hu J; Haseebuddin M; Young M; Colburn NH
Mol Carcinog; 2005 Dec; 44(4):274-84. PubMed ID: 16163708
[TBL] [Abstract][Full Text] [Related]
8. Regulation of NF-κB by ubiquitination and degradation of the IκBs.
Kanarek N; Ben-Neriah Y
Immunol Rev; 2012 Mar; 246(1):77-94. PubMed ID: 22435548
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
Karin M; Ben-Neriah Y
Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
[TBL] [Abstract][Full Text] [Related]
10. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
Morrison TE; Kenney SC
Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
12. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
13. Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability.
Park M; Yong Y; Choi SW; Kim JH; Lee JE; Kim DW
Nat Cell Biol; 2007 Mar; 9(3):287-98. PubMed ID: 17310243
[TBL] [Abstract][Full Text] [Related]
14. [Effect of burn serum on the nuclear translocation of monocytic NF-kappaB p50/p65].
Li ZQ; Huang YS; Yang ZC; Wang JH
Zhonghua Shao Shang Za Zhi; 2004 Oct; 20(5):265-7. PubMed ID: 15730645
[TBL] [Abstract][Full Text] [Related]
15. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
[TBL] [Abstract][Full Text] [Related]
17. CLK2 mediates IκBα-independent early termination of NF-κB activation by inducing cytoplasmic redistribution and degradation.
Li SZ; Shu QP; Zhou HM; Liu YY; Fan MQ; Liang XY; Qi LZ; He YN; Liu XY; Du XH; Huang XC; Chen YZ; Du RL; Liang YX; Zhang XD
Nat Commun; 2024 May; 15(1):3901. PubMed ID: 38724505
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.
Aguilera C; Hoya-Arias R; Haegeman G; Espinosa L; Bigas A
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16537-42. PubMed ID: 15536134
[TBL] [Abstract][Full Text] [Related]
19. Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination.
Diao L; Zhang B; Fan J; Gao X; Sun S; Yang K; Xin D; Jin N; Geng Y; Wang C
Cell Signal; 2005 Feb; 17(2):217-29. PubMed ID: 15494213
[TBL] [Abstract][Full Text] [Related]
20. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
